Differential effects of disease modifying drugs on peripheral blood B cell subsets: A cross sectional study in multiple sclerosis patients treated with interferon-β, glatiramer acetate, dimethyl fumarate, fingolimod or natalizumab

Benutzer: Gast

Dokumenttyp:: Zeitschriftenaufsatz
Autor(en):: Kemmerer, C. L.; Pernpeintner, V.; Ruschil, C.; Abdelhak, A.; Scholl, M.; Ziemann, U.; Krumbholz, M.; Hemmer, B.; Kowarik, M. C.
Titel:: Differential effects of disease modifying drugs on peripheral blood B cell subsets: A cross sectional study in multiple sclerosis patients treated with interferon-β, glatiramer acetate, dimethyl fumarate, fingolimod or natalizumab
Zeitschriftentitel:: PLOS ONE
Jahr:: 2020
Band / Volume:: 15
Heft / Issue:: 7
Seitenangaben Beitrag:: e0235449
Volltext / DOI:: doi:10.1371/journal.pone.0235449
Verlag / Institution:: Public Library of Science (PLoS)
E-ISSN:: 1932-6203
Publikationsdatum:: 27.07.2020
BibTeX

Vorkommen: